Advertisement

Harvard University DNA sequencing system spinout GnuBIO Inc. of Cambridge, which made results from its initial DNA sequencing run available to the Montreal Heart Institute and the Broad Institute, said it is months ahead of its technology and commercial milestones, and plans to ship an early access version of its system to Montreal Heart within a month.

Company CEO and President John Boyce told Mass High Tech that the company hopes to be shipping beta systems in a few months, and final production models in the first quarter of next year.

SOURCE

Advertisement
Advertisement